Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001965071-26-000002

Options or other derivatives

  • Chief Medical Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Puhlmann Markus Chief Medical Officer 2026-03-02 Grant or award · Stock option (right to buy) +150,000 150,000 D
Loading xslF345X05/ownership.xml…